IN8bio Inc (INAB)
0.8994
+0.01
(+1.03%)
USD |
NASDAQ |
Jun 25, 16:00
0.8994
0.00 (0.00%)
After-Hours: 20:00
IN8bio Cash from Operations (Quarterly): -7.919M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -7.919M |
| December 31, 2023 | -4.85M |
| September 30, 2023 | -5.713M |
| June 30, 2023 | -5.338M |
| March 31, 2023 | -7.439M |
| December 31, 2022 | -7.949M |
| September 30, 2022 | -5.741M |
| June 30, 2022 | -5.872M |
| March 31, 2022 | -4.559M |
| Date | Value |
|---|---|
| December 31, 2021 | -2.176M |
| September 30, 2021 | -6.365M |
| June 30, 2021 | -2.461M |
| March 31, 2021 | -2.507M |
| December 31, 2020 | -1.725M |
| September 30, 2020 | -2.124M |
| June 30, 2020 | -1.661M |
| March 31, 2020 | -1.623M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-7.949M
Minimum
Dec 2022
-1.623M
Maximum
Mar 2020
-4.472M
Average
-4.85M
Median
Dec 2023
Cash from Operations (Quarterly) Benchmarks
| Jaguar Health Inc | -7.047M |
| Aptevo Therapeutics Inc | -6.651M |
| NovaBay Pharmaceuticals Inc | -1.572M |
| Palatin Technologies Inc | -8.607M |
| iBio Inc | -3.654M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.071M |
| Cash from Financing (Quarterly) | -0.277M |
| Free Cash Flow | -24.06M |
| Free Cash Flow Per Share (Quarterly) | -0.1846 |
| Free Cash Flow Yield | -78.14% |